Patents by Inventor Taracad K. Ventatachalam

Taracad K. Ventatachalam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cyclohexenyl-ethyl-thiourea compounds and use
    Publication number: 20030125331
    Abstract: Novel CycloHexenyl-Ethyl-Thiourea (CHET) compounds as inhibitors of reverse transcriptase and effective agents for the treatment of HIV infection, including mutant, drug-sensitive, drug-resistant, and multi-drug resistant strains of HIV.
    Type: Application
    Filed: October 22, 2002
    Publication date: July 3, 2003
    Applicant: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Taracad K. Ventatachalam
  • Phenethyl-thiourea compounds and use
    Patent number: 6586450
    Abstract: Novel phenylethyl-thiourea (PHET) compounds as inhibitors of reverse transcriptase and effective agents for the treatment of HIV infection, including mutant, drug-sensitive, drug-resistant, and multi-drug resistant strains of HIV.
    Type: Grant
    Filed: September 7, 2001
    Date of Patent: July 1, 2003
    Assignee: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Taracad K. Ventatachalam
  • Cyclohexenyl-ethyl-thiourea compounds for inhibiting HIV reverse transcriptase
    Patent number: 6469034
    Abstract: Novel CycloHexenyl-Ethyl-Thiourea (CHET) compounds as inhibitors of reverse transcriptase and effective agents for the treatment of HIV infection, including mutant, drug-sensitive, drug-resistant, and multi-drug resistant strains of HIV.
    Type: Grant
    Filed: June 23, 1999
    Date of Patent: October 22, 2002
    Assignee: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Taracad K. Ventatachalam
  • Phenethyl-thiourea compounds and use
    Patent number: 6407246
    Abstract: Novel phenylethyl-thiourea (PHET) compounds as inhibitors of reverse transcriptase and effective agents for the treatment of HIV infection, including mutant, drug-sensitive, drug-resistant, and multi-drug resistant strains of HIV.
    Type: Grant
    Filed: December 20, 2000
    Date of Patent: June 18, 2002
    Assignee: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Taracad K. Ventatachalam
  • Phenethyl-thiourea compounds and use
    Patent number: 6362228
    Abstract: Novel phenylethyl-thiourea (PHET) compounds as inhibitors of reverse transcriptase and effective agents for the treatment of HIV infection, including mutant, drug-sensitive, drug-resistant, and multi-drug resistant strains of HIV.
    Type: Grant
    Filed: December 20, 2000
    Date of Patent: March 26, 2002
    Assignee: Parker Hughes Institute
    Inventors: Faith M. Uckun, Taracad K. Ventatachalam
  • Phenethyl-thiourea compounds and use
    Publication number: 20020028837
    Abstract: Novel phenylethyl-thiourea (PHET) compounds as inhibitors of reverse transcriptase and effective agents for the treatment of HIV infection, including mutant, drug-sensitive, drug-resistant, and multi-drug resistant strains of HIV.
    Type: Application
    Filed: September 7, 2001
    Publication date: March 7, 2002
    Inventors: Fatih M. Uckun, Taracad K. Ventatachalam
  • Phenethyl-thiourea compounds and use
    Publication number: 20010039276
    Abstract: Novel phenylethyl-thiourea (PHET) compounds as inhibitors of reverse transcriptase and effective agents for the treatment of HIV infection, including mutant, drug-sensitive, drug-resistant, and multi-drug resistant strains of HIV.
    Type: Application
    Filed: December 20, 2000
    Publication date: November 8, 2001
    Applicant: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Taracad K. Ventatachalam
  • Phenethyl-thiourea compounds and use
    Publication number: 20010003748
    Abstract: Novel phenylethyl-thiourea (PHET) compounds as inhibitors of reverse transcriptase and effective agents for the treatment of HIV infection, including mutant, drug-sensitive, drug-resistant, and multi-drug resistant strains of HIV.
    Type: Application
    Filed: December 20, 2000
    Publication date: June 14, 2001
    Applicant: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Taracad K. Ventatachalam
  • Phenethyl-thiourea compounds and use
    Patent number: 6207688
    Abstract: Novel phenylethyl-thiourea (PHET) compounds as inhibitors of reverse transcriptase and effective agents for the treatment of HIV infection, including mutant, drug-sensitive, drug-resistant, and multi-drug resistant strains of HIV.
    Type: Grant
    Filed: June 23, 1999
    Date of Patent: March 27, 2001
    Assignee: Parker Hughes Institute
    Inventors: Fatih M. Uckum, Taracad K. Ventatachalam
  • Thiophene-ethyl thiourea compounds and use
    Patent number: 6124324
    Abstract: Novel thiophene-ethyl-thiourea (TET) compounds as inhibitors of reverse transcriptase and effective agents for the treatment of HIV infection, including mutant, drug-sensitive, drug-resistant, and multi-drug resistant strains of HIV.
    Type: Grant
    Filed: June 23, 1999
    Date of Patent: September 26, 2000
    Assignee: Hughes Institute
    Inventors: Fatih M. Uckun, Taracad K. Ventatachalam